Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Mar, 2018 | Pages:
108 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
In this report, the United States Fabry Disease Therapeutic market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Fabry Disease Therapeutic in these regions, from 2013 to 2025 (forecast).
United States Fabry Disease Therapeutic market competition by top manufacturers/players, with Fabry Disease Therapeutic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Amicus therapeutics
Shire
Genzyme-Sanofi
Protalix
Sanofi-Aventis LLC
Novartis Pharmaceuticals
Pfizer
Bristol-Myers Squibb Company
GlaxoSmithKline plc
Amgen Inc.
Teva pharmaceutical Industries Ltd.
Merc & Co.
AbbVie Inc.
Takeda Pharmaceutical Co. Ltd.
Green Cross Corp.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Enzyme Replacement Therapy
Alternative therapies
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospitals
Clinics
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Fabry Disease Therapeutic Market Report 2018
1 Fabry Disease Therapeutic Overview
1.1 Product Overview and Scope of Fabry Disease Therapeutic
1.2 Classification of Fabry Disease Therapeutic by Product Category
1.2.1 United States Fabry Disease Therapeutic Market Size (Sales Volume) Comparison by Type (2013-2025)
1.2.2 United States Fabry Disease Therapeutic Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
1.2.3 Enzyme Replacement Therapy
1.2.4 Alternative therapies
1.3 United States Fabry Disease Therapeutic Market by Application/End Users
1.3.1 United States Fabry Disease Therapeutic Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 United States Fabry Disease Therapeutic Market by Region
1.4.1 United States Fabry Disease Therapeutic Market Size (Value) Comparison by Region (2013-2025)
1.4.2 The West Fabry Disease Therapeutic Status and Prospect (2013-2025)
1.4.3 Southwest Fabry Disease Therapeutic Status and Prospect (2013-2025)
1.4.4 The Middle Atlantic Fabry Disease Therapeutic Status and Prospect (2013-2025)
1.4.5 New England Fabry Disease Therapeutic Status and Prospect (2013-2025)
1.4.6 The South Fabry Disease Therapeutic Status and Prospect (2013-2025)
1.4.7 The Midwest Fabry Disease Therapeutic Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Fabry Disease Therapeutic (2013-2025)
1.5.1 United States Fabry Disease Therapeutic Sales and Growth Rate (2013-2025)
1.5.2 United States Fabry Disease Therapeutic Revenue and Growth Rate (2013-2025)
2 United States Fabry Disease Therapeutic Market Competition by Players/Suppliers
2.1 United States Fabry Disease Therapeutic Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Fabry Disease Therapeutic Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Fabry Disease Therapeutic Average Price by Players/Suppliers (2013-2018)
2.4 United States Fabry Disease Therapeutic Market Competitive Situation and Trends
2.4.1 United States Fabry Disease Therapeutic Market Concentration Rate
2.4.2 United States Fabry Disease Therapeutic Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Fabry Disease Therapeutic Manufacturing Base Distribution, Sales Area, Product Type
3 United States Fabry Disease Therapeutic Sales (Volume) and Revenue (Value) by Region (2013-2018)
3.1 United States Fabry Disease Therapeutic Sales and Market Share by Region (2013-2018)
3.2 United States Fabry Disease Therapeutic Revenue and Market Share by Region (2013-2018)
3.3 United States Fabry Disease Therapeutic Price by Region (2013-2018)
4 United States Fabry Disease Therapeutic Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)
4.1 United States Fabry Disease Therapeutic Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Fabry Disease Therapeutic Revenue and Market Share by Type (2013-2018)
4.3 United States Fabry Disease Therapeutic Price by Type (2013-2018)
4.4 United States Fabry Disease Therapeutic Sales Growth Rate by Type (2013-2018)
5 United States Fabry Disease Therapeutic Sales (Volume) by Application (2013-2018)
5.1 United States Fabry Disease Therapeutic Sales and Market Share by Application (2013-2018)
5.2 United States Fabry Disease Therapeutic Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities
6 United States Fabry Disease Therapeutic Players/Suppliers Profiles and Sales Data
6.1 Amicus therapeutics
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Fabry Disease Therapeutic Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Amicus therapeutics Fabry Disease Therapeutic Sales, Revenue, Price and Gross Margin (2013-2018)
6.1.4 Main Business/Business Overview
6.2 Shire
6.2.2 Fabry Disease Therapeutic Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Shire Fabry Disease Therapeutic Sales, Revenue, Price and Gross Margin (2013-2018)
6.2.4 Main Business/Business Overview
6.3 Genzyme-Sanofi
6.3.2 Fabry Disease Therapeutic Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Genzyme-Sanofi Fabry Disease Therapeutic Sales, Revenue, Price and Gross Margin (2013-2018)
6.3.4 Main Business/Business Overview
6.4 Protalix
6.4.2 Fabry Disease Therapeutic Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Protalix Fabry Disease Therapeutic Sales, Revenue, Price and Gross Margin (2013-2018)
6.4.4 Main Business/Business Overview
6.5 Sanofi-Aventis LLC
6.5.2 Fabry Disease Therapeutic Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sanofi-Aventis LLC Fabry Disease Therapeutic Sales, Revenue, Price and Gross Margin (2013-2018)
6.5.4 Main Business/Business Overview
6.6 Novartis Pharmaceuticals
6.6.2 Fabry Disease Therapeutic Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Novartis Pharmaceuticals Fabry Disease Therapeutic Sales, Revenue, Price and Gross Margin (2013-2018)
6.6.4 Main Business/Business Overview
6.7 Pfizer
6.7.2 Fabry Disease Therapeutic Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Pfizer Fabry Disease Therapeutic Sales, Revenue, Price and Gross Margin (2013-2018)
6.7.4 Main Business/Business Overview
6.8 Bristol-Myers Squibb Company
6.8.2 Fabry Disease Therapeutic Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Bristol-Myers Squibb Company Fabry Disease Therapeutic Sales, Revenue, Price and Gross Margin (2013-2018)
6.8.4 Main Business/Business Overview
6.9 GlaxoSmithKline plc
6.9.2 Fabry Disease Therapeutic Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 GlaxoSmithKline plc Fabry Disease Therapeutic Sales, Revenue, Price and Gross Margin (2013-2018)
6.9.4 Main Business/Business Overview
6.10 Amgen Inc.
6.10.2 Fabry Disease Therapeutic Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Amgen Inc. Fabry Disease Therapeutic Sales, Revenue, Price and Gross Margin (2013-2018)
6.10.4 Main Business/Business Overview
6.11 Teva pharmaceutical Industries Ltd.
6.12 Merc & Co.
6.13 AbbVie Inc.
6.14 Takeda Pharmaceutical Co. Ltd.
6.15 Green Cross Corp.
7 Fabry Disease Therapeutic Manufacturing Cost Analysis
7.1 Fabry Disease Therapeutic Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Fabry Disease Therapeutic
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Fabry Disease Therapeutic Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Fabry Disease Therapeutic Major Manufacturers in 2017
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Fabry Disease Therapeutic Market Size (Value and Volume) Forecast (2018-2025)
11.1 United States Fabry Disease Therapeutic Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Fabry Disease Therapeutic Sales Volume Forecast by Type (2018-2025)
11.3 United States Fabry Disease Therapeutic Sales Volume Forecast by Application (2018-2025)
11.4 United States Fabry Disease Therapeutic Sales Volume Forecast by Region (2018-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Fabry Disease Therapeutic
Figure United States Fabry Disease Therapeutic Market Size (K Units) by Type (2013-2025)
Figure United States Fabry Disease Therapeutic Sales Volume Market Share by Type (Product Category) in 2017
Figure Enzyme Replacement Therapy Product Picture
Figure Alternative therapies Product Picture
Figure United States Fabry Disease Therapeutic Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Fabry Disease Therapeutic by Application in 2017
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure United States Fabry Disease Therapeutic Market Size (Million USD) by Region (2013-2025)
Figure The West Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Fabry Disease Therapeutic Sales (K Units) and Growth Rate (2013-2025)
Figure United States Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Fabry Disease Therapeutic Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Fabry Disease Therapeutic Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Fabry Disease Therapeutic Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Fabry Disease Therapeutic Sales Share by Players/Suppliers
Figure 2017 United States Fabry Disease Therapeutic Sales Share by Players/Suppliers
Figure United States Fabry Disease Therapeutic Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Fabry Disease Therapeutic Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Fabry Disease Therapeutic Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Fabry Disease Therapeutic Revenue Share by Players/Suppliers
Figure 2017 United States Fabry Disease Therapeutic Revenue Share by Players/Suppliers
Table United States Market Fabry Disease Therapeutic Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Fabry Disease Therapeutic Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Fabry Disease Therapeutic Market Share of Top 3 Players/Suppliers
Figure United States Fabry Disease Therapeutic Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Fabry Disease Therapeutic Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Fabry Disease Therapeutic Product Category
Table United States Fabry Disease Therapeutic Sales (K Units) by Region (2013-2018)
Table United States Fabry Disease Therapeutic Sales Share by Region (2013-2018)
Figure United States Fabry Disease Therapeutic Sales Share by Region (2013-2018)
Figure United States Fabry Disease Therapeutic Sales Market Share by Region in 2017
Table United States Fabry Disease Therapeutic Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Fabry Disease Therapeutic Revenue Share by Region (2013-2018)
Figure United States Fabry Disease Therapeutic Revenue Market Share by Region (2013-2018)
Figure United States Fabry Disease Therapeutic Revenue Market Share by Region in 2017
Table United States Fabry Disease Therapeutic Price (USD/Unit) by Region (2013-2018)
Table United States Fabry Disease Therapeutic Sales (K Units) by Type (2013-2018)
Table United States Fabry Disease Therapeutic Sales Share by Type (2013-2018)
Figure United States Fabry Disease Therapeutic Sales Share by Type (2013-2018)
Figure United States Fabry Disease Therapeutic Sales Market Share by Type in 2017
Table United States Fabry Disease Therapeutic Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Fabry Disease Therapeutic Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Fabry Disease Therapeutic by Type (2013-2018)
Figure Revenue Market Share of Fabry Disease Therapeutic by Type in 2017
Table United States Fabry Disease Therapeutic Price (USD/Unit) by Types (2013-2018)
Figure United States Fabry Disease Therapeutic Sales Growth Rate by Type (2013-2018)
Table United States Fabry Disease Therapeutic Sales (K Units) by Application (2013-2018)
Table United States Fabry Disease Therapeutic Sales Market Share by Application (2013-2018)
Figure United States Fabry Disease Therapeutic Sales Market Share by Application (2013-2018)
Figure United States Fabry Disease Therapeutic Sales Market Share by Application in 2017
Table United States Fabry Disease Therapeutic Sales Growth Rate by Application (2013-2018)
Figure United States Fabry Disease Therapeutic Sales Growth Rate by Application (2013-2018)
Table Amicus therapeutics Basic Information List
Table Amicus therapeutics Fabry Disease Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amicus therapeutics Fabry Disease Therapeutic Sales Growth Rate (2013-2018)
Figure Amicus therapeutics Fabry Disease Therapeutic Sales Market Share in United States (2013-2018)
Figure Amicus therapeutics Fabry Disease Therapeutic Revenue Market Share in United States (2013-2018)
Table Shire Basic Information List
Table Shire Fabry Disease Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Shire Fabry Disease Therapeutic Sales Growth Rate (2013-2018)
Figure Shire Fabry Disease Therapeutic Sales Market Share in United States (2013-2018)
Figure Shire Fabry Disease Therapeutic Revenue Market Share in United States (2013-2018)
Table Genzyme-Sanofi Basic Information List
Table Genzyme-Sanofi Fabry Disease Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Genzyme-Sanofi Fabry Disease Therapeutic Sales Growth Rate (2013-2018)
Figure Genzyme-Sanofi Fabry Disease Therapeutic Sales Market Share in United States (2013-2018)
Figure Genzyme-Sanofi Fabry Disease Therapeutic Revenue Market Share in United States (2013-2018)
Table Protalix Basic Information List
Table Protalix Fabry Disease Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Protalix Fabry Disease Therapeutic Sales Growth Rate (2013-2018)
Figure Protalix Fabry Disease Therapeutic Sales Market Share in United States (2013-2018)
Figure Protalix Fabry Disease Therapeutic Revenue Market Share in United States (2013-2018)
Table Sanofi-Aventis LLC Basic Information List
Table Sanofi-Aventis LLC Fabry Disease Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sanofi-Aventis LLC Fabry Disease Therapeutic Sales Growth Rate (2013-2018)
Figure Sanofi-Aventis LLC Fabry Disease Therapeutic Sales Market Share in United States (2013-2018)
Figure Sanofi-Aventis LLC Fabry Disease Therapeutic Revenue Market Share in United States (2013-2018)
Table Novartis Pharmaceuticals Basic Information List
Table Novartis Pharmaceuticals Fabry Disease Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Pharmaceuticals Fabry Disease Therapeutic Sales Growth Rate (2013-2018)
Figure Novartis Pharmaceuticals Fabry Disease Therapeutic Sales Market Share in United States (2013-2018)
Figure Novartis Pharmaceuticals Fabry Disease Therapeutic Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Fabry Disease Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Fabry Disease Therapeutic Sales Growth Rate (2013-2018)
Figure Pfizer Fabry Disease Therapeutic Sales Market Share in United States (2013-2018)
Figure Pfizer Fabry Disease Therapeutic Revenue Market Share in United States (2013-2018)
Table Bristol-Myers Squibb Company Basic Information List
Table Bristol-Myers Squibb Company Fabry Disease Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Fabry Disease Therapeutic Sales Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Fabry Disease Therapeutic Sales Market Share in United States (2013-2018)
Figure Bristol-Myers Squibb Company Fabry Disease Therapeutic Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Fabry Disease Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline plc Fabry Disease Therapeutic Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline plc Fabry Disease Therapeutic Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline plc Fabry Disease Therapeutic Revenue Market Share in United States (2013-2018)
Table Amgen Inc. Basic Information List
Table Amgen Inc. Fabry Disease Therapeutic Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Amgen Inc. Fabry Disease Therapeutic Sales Growth Rate (2013-2018)
Figure Amgen Inc. Fabry Disease Therapeutic Sales Market Share in United States (2013-2018)
Figure Amgen Inc. Fabry Disease Therapeutic Revenue Market Share in United States (2013-2018)
Table Teva pharmaceutical Industries Ltd. Basic Information List
Table Merc & Co. Basic Information List
Table AbbVie Inc. Basic Information List
Table Takeda Pharmaceutical Co. Ltd. Basic Information List
Table Green Cross Corp. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fabry Disease Therapeutic
Figure Manufacturing Process Analysis of Fabry Disease Therapeutic
Figure Fabry Disease Therapeutic Industrial Chain Analysis
Table Raw Materials Sources of Fabry Disease Therapeutic Major Players/Suppliers in 2017
Table Major Buyers of Fabry Disease Therapeutic
Table Distributors/Traders List
Figure United States Fabry Disease Therapeutic Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Fabry Disease Therapeutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Fabry Disease Therapeutic Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Fabry Disease Therapeutic Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Fabry Disease Therapeutic Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Fabry Disease Therapeutic Sales Volume (K Units) Forecast by Type in 2025
Table United States Fabry Disease Therapeutic Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Fabry Disease Therapeutic Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Fabry Disease Therapeutic Sales Volume (K Units) Forecast by Application in 2025
Table United States Fabry Disease Therapeutic Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Fabry Disease Therapeutic Sales Volume Share Forecast by Region (2018-2025)
Figure United States Fabry Disease Therapeutic Sales Volume Share Forecast by Region (2018-2025)
Figure United States Fabry Disease Therapeutic Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
